- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
CDPQ divests 0.89 percent stake in Piramal Pharma for Rs 100 crore
Vanguard Group acquired more than 62 lakh shares of Piramal Pharma at an average price of Rs 94.71 per share, while other buyer(s) identity is not known.
New Delhi: CDPQ on Friday divested a 0.89% stake in Piramal Pharma Ltd for Rs 100 crore through an open market transaction.
Caisse De Depot Et Placement Du Quebec is a global investment group.
According to the bulk deal data available with the National Stock Exchange, CDPQ offloaded a total of 1,05,70,466 shares, amounting to a 0.89% stake in Piramal Pharma.
The shares were sold at an average price of Rs 94.48 apiece, taking the transaction size to Rs 99.86 crore.
Post the latest transaction, CDPQ's shareholding has been reduced to 4.64% from 5.53% at March-end.
Meanwhile, Vanguard Group acquired more than 62 lakh shares of Piramal Pharma at an average price of Rs 94.71 per share, while other buyer(s) identity is not known.
Shares of Piramal Pharma went up 3.04% to close at Rs 94.95 per piece on the NSE.
Piramal Pharma Limited (PPL) offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS), an integrated Contract Development and Manufacturing Organization; Piramal Critical Care (PCC), a Complex Hospital Generics business, and the India Consumer Healthcare business selling over-the-counter products.
Read also: Piramal Pharma Solutions, Plus Therapeutics expand collaboration for cGMP drug production
In a separate bulk deal, SmallCap World Fund Inc offloaded more than 7 lakh shares of Aavas Financiers for nearly Rs 96 crore through an open market transaction.
SmallCap World Fund Inc sold 7,08,978 shares, amounting to a 0.90% stake in Aavas Financiers Ltd, as per the data available with the NSE.
Shares were disposed of at an average price of Rs 1,350.02 apiece, taking the deal value to Rs 95.71 crore.
Details of the buyers could not be ascertained.
On Friday, shares of Aavas Financiers gained 0.98% to settle at Rs 1,353.70 apiece on the NSE
Read also: Piramal Critical Care ropes in Jeffrey Hampton as President, COO
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751